World's Best Scientists 2026 revealed!
Johan Maertens

Johan Maertens

D-Index & Metrics

Medicine

D-Index
107
Citations
59744
World Ranking
6125
National Ranking
68

Research.com Recognitions

  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Johan Maertens is affiliated with KU Leuven in Belgium and has an extensive publication record primarily in the field of medicine, with a focus on hematology, infectious diseases, epidemiology, oncology, and public health. Their research contributions span over 600 publications, among which hematology is the most prominent subfield.

Their work frequently addresses topics such as acute myeloid leukemia research, antifungal resistance and susceptibility, hematopoietic stem cell transplantation, fungal infections and studies, acute lymphoblastic leukemia research, neutropenia and cancer infections, and chronic myeloid leukemia treatments.

Key publication venues in which Maertens has published include:

  • Blood (39 publications)
  • Bone Marrow Transplantation (29 publications)
  • Clinical Infectious Diseases (14 publications)
  • Leukemia (13 publications)
  • Haematologica (8 publications)

Prominent recent papers authored by Maertens consist of:

  • "Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion," 2020, Intensive Care Medicine
  • "COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)," 2021, Journal of Hematology & Oncology
  • "Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial," 2021, Clinical Infectious Diseases
  • "Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome," 2022, Blood
  • "Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial," 2021, The Lancet

Collaborations have involved frequent co-authors including Katrien Lagrou, Mohamad Mohty, Jakob Passweg, Didier Blaise, and Patrice Chevallier, with each co-author appearing in multiple publications.

Maertens holds the distinction of being a Fellow of the European Confederation of Medical Mycology (ECMM).

Best Publications

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

    Oliver A. Cornely;Johan Maertens;Drew J. Winston;John Perfect

  • Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

    Stefan Janssens;Christophe Dubois;Jan Bogaert;Koen Theunissen

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

    Thomas J Walsh;Hedy Teppler;Gerald R Donowitz;Johan A Maertens

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • High-dose daunorubicin in older patients with acute myeloid leukemia.

    Bob Löwenberg;Gert J. Ossenkoppele;Wim van Putten;Harry C. Schouten

  • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  • Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

    Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi

  • Galactomannan and Computed Tomography–Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

    Johan Maertens;Koen Theunissen;Gregor Verhoef;Johnny Verschakelen

  • Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

    Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts

  • Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

    Johan Maertens;Jan Verhaegen;Katrien Lagrou;Johan Van Eldere

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

    Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

    Wouter Meersseman;Katrien Lagrou;Johan Maertens;Alexander Wilmer

  • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

    J Maertens;O Marchetti;R Herbrecht;O A Cornely

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Myriam Labopin
Myriam Labopin Université Paris Cité
Gérard Socié
Gérard Socié Université Paris Cité
Jakob Passweg
Jakob Passweg University Hospital of Basel
Jürgen Finke
Jürgen Finke University of Freiburg
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are many flexible online options for those interested in advancing their nursing or healthcare career in the USA. Programs such as online rn to bsn programs without clinical requirements are designed for working nurses seeking to earn a bachelor's degree with minimal disruption to their schedules.

For those aiming for leadership roles, pursuing accelerated msn to dnp programs can help you achieve a Doctor of Nursing Practice degree in less time. Additionally, many nurses opt for dnp online programs to further their expertise and open up advanced clinical and administrative opportunities—all from the comfort of home.

Aspiring nurses looking to enter the workforce quickly may consider accelerated lpn training, which allows for a fast track into practical nursing. Exploring these online pathways can provide more flexibility, convenience, and a broader range of career opportunities in the ever-evolving field of medicine.

Best Scientists Citing Johan Maertens

Trending Scientists

Recently Published Articles